Nutex Health (NUTX) vs QuinStreet (QNST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
QuinStreet (QNST) has outperformed Nutex Health (NUTX) over the past year, gaining 35.7% versus a gain of 18.8%. Nutex Health is the larger company by market cap ($1.12 billion vs $1.06 billion), about 1.1 times the size. On valuation, Nutex Health trades at a lower forward P/E (8.0x vs 9.6x for QuinStreet).
Nutex Health converts more of its revenue into profit, with a net margin of 8.1% versus 6.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NUTX | QNST |
|---|---|---|
| Share price | $162.64 | $18.49 |
| Market cap | $1.12B | $1.06B |
| 1-day change | +0.33% | -2.74% |
| YTD return | -1.20% | +28.67% |
| 1-year return | +18.78% | +35.66% |
| 5-year return | — | +18.91% |
| P/E ratio (TTM) | 7.04 | 11.41 |
| Forward P/E | 8.00 | 9.57 |
| EPS (TTM) | $23.11 | $1.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $875.26M | $1.29B |
| Revenue growth (YoY) | +82.36% | +18.29% |
| Net income (latest FY) | $70.79M | $81.23M |
| Gross margin | 50.76% | 11.27% |
| Operating margin | 31.49% | 2.74% |
| Net margin | 8.09% | 6.28% |
| 52-week high | $226.16 | $22.29 |
| 52-week low | $83.99 | $10.29 |
| Distance from 52-week high | -28.09% | -17.05% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +92.86% | +36.13% |
| Average volume | 149.94K | 962.47K |
| Shares outstanding | 6.86M | 57.29M |
| Employees | 1,093 | 1,074 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Business Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QNST has outperformed NUTX by 16.9 percentage points over the past year.
- QuinStreet trades at a higher earnings multiple (11.4x vs 7.0x trailing P/E).
- Nutex Health grew revenue faster in its latest fiscal year (+82.36% vs +18.29%).
About Nutex Health
NUTX stock →Nutex Health Inc. operates as a healthcare services and operations company in the United States.
Consumer Discretionary · Business Services · 1,093 employees
About QuinStreet
QNST stock →QuinStreet, Inc., an online performance marketing company, provides customer acquisition services for its clients in the United States and internationally. The company provides online marketing services, such as qualified clicks, leads, calls, applications, and customers through its websites or third-party publishers to financial and home services industries.
Consumer Discretionary · Business Services · 1,074 employees
NUTX vs QNST FAQ
Which is bigger, Nutex Health or QuinStreet?
Nutex Health (NUTX) is larger, with a market capitalization of $1.12B compared with $1.06B for QuinStreet (QNST).
Which stock has performed better over the past year, NUTX or QNST?
QNST returned +35.66% over the past 12 months, compared with +18.78% for NUTX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, NUTX or QNST?
NUTX has the lower trailing P/E at 7.0, versus 11.4 for QNST. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Nutex Health and QuinStreet in the same industry?
Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.